-
The Truth About Multivitamins; Statins and Hepatitis C; Preventing Hot
Flashes; FDA News
-
A recently published study using a large national administrative database found that only two-thirds of patients hospitalized with exacerbations of chronic obstructive pulmonary disease (COPD) received care that was consistent with current guidelines of the American College of Physicians and the American College of Chest Physicians.
-
-
Exacerbations of chronic obstructive pulmonary disease (COPD) are an important cause of morbidity and mortality, and have substantial economic consequences.
-
In this study from the University Hospital A Calmette in Lille, France, patients with known COPD who were admitted because of acute respiratory deterioration were evaluated for inclusion in a prospective investigation of the prevalence and risk factors for pulmonary thromboembolism (PE) in this setting.
-
Treating Chronic Primary Insomnia; New Breakthrough in Smoking Cessation?; FDA Actions
-
Proper fluid management of patients with acute lung injury (ALI) or the acute respiratory distress syndrome (ARDS) is important. Although the pulmonary edema in ARDS patients is not due to increased hydrostatic pressures, it is believed that there is more fluid leakage at higher pressures.
-
Corticosteroids have been studied in various phases in the treatment of Acute Respiratory Distress Syndrome (ARDS), which is characterized by an inflammatory injury to the lung resulting in acute hypoxemic respiratory failure. Four trials of steroids in early ARDS failed to show any improvement.
-
Summary Content
The STAR Trial (Tamoxifen and Raloxifene); FDA Actions
-
One in 5 Americans dies in or shortly after discharge from an intensive care unit (ICU), an outcome that exposes critical care clinicians to frequent discussions that concern end-of-life care.